Dr. Ghassan Abou-Alfa, MD, of Memorial Sloan Kettering Cancer Center, explains that participation in clinical trials is entirely voluntary, with full respect for patient
choice,
safety, and
privacy. Personal information remains confidential, and data is anonymized. If safety issues arise, they are promptly addressed. An
Institutional Review Board (
IRB), which includes patient representatives, oversees a trial to ensure ethical conduct, protect participants, and evaluate risks and benefits. Dr. Abou-Alfa concludes with gratitude for patients and their families, recognizing their vital role in advancing research through partnership with physicians and researchers.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about liver cancer which will help other patients, caregivers, and families.